Some accumulation on this Canadian biotech.
On January 18, André Desmarais bought 100,000 shares at $18.20.
Between April 7 and 10, Denis Garceau bought 19,500 shares at an average cost of $15.24.
On March 2, Frederick Iowy bought 1,000 shares at $16.60.
Salutations,
G.L.